155 related articles for article (PubMed ID: 1486864)
1. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
[TBL] [Abstract][Full Text] [Related]
2. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer.
Weston A; Ling-Cawley HM; Caporaso NE; Bowman ED; Hoover RN; Trump BF; Harris CC
Carcinogenesis; 1994 Apr; 15(4):583-7. PubMed ID: 7908608
[TBL] [Abstract][Full Text] [Related]
3. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population.
Pierce LM; Sivaraman L; Chang W; Lum A; Donlon T; Seifried A; Wilkens LR; Lau AF; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1199-204. PubMed ID: 11097227
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.
Ishibe N; Wiencke JK; Zuo ZF; McMillan A; Spitz M; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1075-80. PubMed ID: 9419406
[TBL] [Abstract][Full Text] [Related]
5. Allelic frequency of a p53 polymorphism in human lung cancer.
Weston A; Perrin LS; Forrester K; Hoover RN; Trump BF; Harris CC; Caporaso NE
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):481-3. PubMed ID: 1302561
[TBL] [Abstract][Full Text] [Related]
6. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
Wu X; Zhao H; Amos CI; Shete S; Makan N; Hong WK; Kadlubar FF; Spitz MR
J Natl Cancer Inst; 2002 May; 94(9):681-90. PubMed ID: 11983757
[TBL] [Abstract][Full Text] [Related]
7. Association of L-myc polymorphism with lung cancer susceptibility and prognosis in relation to age-selected controls and stratified cases.
Shih CM; Kuo YY; Wang YC; Jian SL; Hsu YT; Wu HY; Guo MW; Wang YC
Lung Cancer; 2002 May; 36(2):125-32. PubMed ID: 11955646
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.
Zborovskaya I; Gasparian A; Kitaeva M; Polotzky B; Tupitzin N; Machaladze Z; Gerasimov S; Shtutman M; Jakubovskaya M; Davidov M; Tatosyan A
Clin Exp Metastasis; 1996 Nov; 14(6):490-500. PubMed ID: 8970579
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis.
Weston A; Godbold JH
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):919-26. PubMed ID: 9255581
[TBL] [Abstract][Full Text] [Related]
10. Gene analysis of K-, H-ras, p53, and retinoblastoma susceptibility genes in human lung cancer cell lines by the polymerase chain reaction/single-strand conformation polymorphism method.
Kashii T; Mizushima Y; Monno S; Nakagawa K; Kobayashi M
J Cancer Res Clin Oncol; 1994; 120(3):143-8. PubMed ID: 8263009
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Leathart JB; Navidi WC; Carpenter CC; Idle JR
Carcinogenesis; 1997 Jun; 18(6):1203-14. PubMed ID: 9214604
[TBL] [Abstract][Full Text] [Related]
12. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype.
Jin X; Wu X; Roth JA; Amos CI; King TM; Branch C; Honn SE; Spitz MR
Carcinogenesis; 1995 Sep; 16(9):2205-8. PubMed ID: 7554076
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County.
London SJ; Daly AK; Cooper J; Carpenter CL; Navidi WC; Ding L; Idle JR
Pharmacogenetics; 1996 Apr; 6(2):151-8. PubMed ID: 9156693
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer, race, and a CYP1A1 genetic polymorphism.
Shields PG; Caporaso NE; Falk RT; Sugimura H; Trivers GE; Trump BF; Hoover RN; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):481-5. PubMed ID: 8220094
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.
Cesarman E; Chadburn A; Inghirami G; Gaidano G; Knowles DM
Blood; 1992 Dec; 80(12):3205-16. PubMed ID: 1361372
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.
London SJ; Daly AK; Cooper J; Navidi WC; Carpenter CL; Idle JR
J Natl Cancer Inst; 1995 Aug; 87(16):1246-53. PubMed ID: 7563171
[TBL] [Abstract][Full Text] [Related]
18. D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: a lung cancer case-control study.
Wu X; Hudmon KS; Detry MA; Chamberlain RM; Spitz MR
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1021-6. PubMed ID: 11045783
[TBL] [Abstract][Full Text] [Related]
19. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Marangoz S; Güllü IH
Cancer; 1999 Jun; 85(12):2668-9. PubMed ID: 10375117
[No Abstract] [Full Text] [Related]
20. Analysis of cytochrome P450 2E1 genetic polymorphisms in relation to human lung cancer.
Kato S; Shields PG; Caporaso NE; Sugimura H; Trivers GE; Tucker MA; Trump BF; Weston A; Harris CC
Cancer Epidemiol Biomarkers Prev; 1994 Sep; 3(6):515-8. PubMed ID: 8000304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
